Surveillance for hepatitis B surface antigen mutants

Journal of Medical Virology

Volumn 78, Issue SUPPL. 1, 2006, Pages

  Coleman, Paul F ^a,b  

^a ABBOTT DIAGNOSTICS   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Epitopes; HBsAg; Hepatitis B virus; Immunoassay; Mutations

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ARTICLE; GENETIC SELECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; MOLECULAR EPIDEMIOLOGY; NONHUMAN; VIRUS DETECTION; VIRUS MUTANT;

FALSE NEGATIVE REACTIONS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOASSAY; MUTATION; SENTINEL SURVEILLANCE;

HEPATITIS B VIRUS;

EID: 33745602769     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20609     Document Type: Article

References (15)

1. Carman W. 1997. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hep 4:11-20.
2. Carman W, Van Deursen F, Mimms L, Hardie D, Coppola R, Decker R, Sanders R. 1997. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 26:1658-1666.
3. Coleman P, Chen Y-C, Mushahwar IK. 1999. Immunoassay detection of hepatitis B surface antigen mutants. J. Med. Virol 59:19-24.
4. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. 1999. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30:1312-1317.
5. Ireland J, O'Donnell B, Basuni A, Kean J, Wallace L, Lau G, Carman W. 2000. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 31:1176-1182.
6. Jongerius J, Wester M, Cuypers H, van Oostendorp W, Lelie P, van der Poel C, van Leeuwen E. 1998. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 38:56-59.
7. Kao JH, Chen DS. 2002. Global control of hepatitis B virus. Lancet Infect Dis 2:395-403.
8. Locarnini S. 2003. Hepatitis B viral resistance: Mechanisms and diagnosis. J Hep 39(suppl):S124-S132.
9. Louisirirotchanakul S, Kanoksinsombat C, Theamboonlert A, Puthavatana P, Wasi C, Poovorawan Y. 2004. Mutation of the "a" determinant of HBsAg with discordant HBsAg diagnostic kits. Viral Immunol 17:440-444.
10. Margeridon S, Lachaux A, Trepo C, Zoulim F, Kay A. 2005. A quasi-monoclonal anti-HBs response can lead to immune escape of 'wild-type' hepatitis B virus. J Gen Virol 86:1687-1693.
11. Nainan O, Khristova M, Byun K, Xia G, Taylor P, Stevens C, Margolis H. 2002. Genetic variation of hepatitis B surface antigen coding region amonginfants with chronic hepatitis B virus infection. J Med Virol 68:319-327.
12. Oon C, Lim G, Ye Z, Goh K, Tan K, Yo S, Hopes E, Harrison T, Zuckerman A. 1995. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 13:699-702.
13. Torresi J, Earnest-Silveira L, Civitico G, Walters TE, Lewin SR, Fyfe J, Locarnini SA, Manns M, Trautwein C, Bock TC. 2002. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene. Virology 299:88-99.
14. Weinberger K, Bauer T, Bohm S, Jilg W. 2000. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Vir 81:1165-1174.
15. Zuckerman J, Zuckerman A. 2003. Mutations of the surface protein of hepatitis B virus. Antiviral Res 60:75-78.